nivolumab,bevacizumab
roche,bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'nivo', 'nivacor', 'nivolumab', 'beva', '3509', 'bevacizumab']
nivacor trail abstr. 3509, first efficacy and safety data for folfoxiri/bevacizumab + nivolumab in 1st line mutant braf/ras crc orr 76.7%, mpfs 10.1 months, interesting, but #crc #immuntherapy 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine